Literature DB >> 12829232

Phosphoinositide signaling disorders in human diseases.

Caroline Pendaries1, Hélène Tronchère, Monique Plantavid, Bernard Payrastre.   

Abstract

Phosphoinositides (PIs) play an essential role in diverse cellular functions. Their intracellular level is strictly regulated by specific PI kinases, phosphatases and phospholipases. Recent discoveries indicate that dysfunctions in the control of their level often lead to pathologies. This review will focus on some human diseases whose etiologies involve PI-metabolizing enzymes. The role of PTEN (phosphatase and tensin homolog deleted on chromosome ten) in cancer, the impact of the Src homology 2-containing inositol-5-phosphatase phosphatases in acute myeloid leukemia or diabetes, the involvement of myotubularin family members in genetic diseases and the implication of OCRL1 in Lowe syndrome will be emphasized. We will also review how some bacterial pathogens have evolved strategies to specifically manipulate the host cell PI metabolism to efficiently infect them.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829232     DOI: 10.1016/s0014-5793(03)00437-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  45 in total

1.  Phosphatidylinositol 3,4,5-trisphosphate activity probes for the labeling and proteomic characterization of protein binding partners.

Authors:  Meng M Rowland; Heidi E Bostic; Denghuang Gong; Anna E Speers; Nathan Lucas; Wonhwa Cho; Benjamin F Cravatt; Michael D Best
Journal:  Biochemistry       Date:  2011-11-30       Impact factor: 3.162

Review 2.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

3.  Identification of nuclear phosphatidylinositol 4,5-bisphosphate-interacting proteins by neomycin extraction.

Authors:  Aurélia E Lewis; Lilly Sommer; Magnus Ø Arntzen; Yvan Strahm; Nicholas A Morrice; Nullin Divecha; Clive S D'Santos
Journal:  Mol Cell Proteomics       Date:  2010-11-03       Impact factor: 5.911

4.  PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression.

Authors:  Sandra Jurado; Marion Benoist; Argentina Lario; Shira Knafo; Cortney N Petrok; José A Esteban
Journal:  EMBO J       Date:  2010-07-13       Impact factor: 11.598

5.  Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cζ/λ (PKCζ/λ) in 3T3l1 adipocytes.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 6.  Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Cell Physiol Biochem       Date:  2015-02-11

7.  A molecular dynamics investigation of lipid bilayer perturbation by PIP2.

Authors:  Dmitry Lupyan; Mihaly Mezei; Diomedes E Logothetis; Roman Osman
Journal:  Biophys J       Date:  2010-01-20       Impact factor: 4.033

8.  OCRL1 mutations in patients with Dent disease phenotype in Japan.

Authors:  Takashi Sekine; Kandai Nozu; Rashmi Iyengar; Xue Jun Fu; Masafumi Matsuo; Ryojiro Tanaka; Kazumoto Iijima; Emiko Matsui; Yutaka Harita; Jun Inatomi; Takashi Igarashi
Journal:  Pediatr Nephrol       Date:  2007-03-24       Impact factor: 3.714

Review 9.  Regulation of ATP-gated P2X receptors by phosphoinositides.

Authors:  Qi Zhao; Diomedes E Logothetis; Philippe Séguéla
Journal:  Pflugers Arch       Date:  2007-05-04       Impact factor: 3.657

10.  Quantitative analysis of the binding of ezrin to large unilamellar vesicles containing phosphatidylinositol 4,5 bisphosphate.

Authors:  Guillaume Blin; Emmanuel Margeat; Kévin Carvalho; Catherine A Royer; Christian Roy; Catherine Picart
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.